ライフサイエンスコーパス: cutaneous malignant melanoma

1 n radically resected stage IIB and stage III cutaneous malignant melanoma.

2 d 5529 female) first diagnosed with invasive cutaneous malignant melanoma.

3 nd has been implicated in the development of cutaneous malignant melanoma.

4 as determined in 139 Caucasian patients with cutaneous malignant melanoma.

5 contribute to the genesis and progression of cutaneous malignant melanoma, a complex and aggressive d

6 al copy number gains within chromosome 3p in cutaneous malignant melanoma and suggest that deregulati

7 evidence regarding the effect of sunburns on cutaneous malignant melanoma and the possible effectiven

8 is a paraneoplastic syndrome associated with cutaneous malignant melanoma and the presence of autoant

9 re is strongly implicated in the etiology of cutaneous malignant melanoma and the UV portion of the s

10 contribute to the genesis and progression of cutaneous malignant melanoma are poorly understood, attr

11 We prospectively evaluated the risk of cutaneous malignant melanoma associated with citrus cons

12 segmental 1.8 - 11-fold chromosomal gains in cutaneous malignant melanoma cell lines (5/13; 40%) and

13 Known high-risk cutaneous malignant melanoma (CMM) genes account for mel

14 The incidence of cutaneous malignant melanoma (CMM) has more than doubled

15 mechanisms underlying the high prevalence of cutaneous malignant melanoma (CMM) in Parkinson disease

16 Cutaneous malignant melanoma (CMM), already known for it

17 lastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequently oc

18 nown to be associated with susceptibility to cutaneous malignant melanoma (CMM), but the mechanisms u

19 redisposition genes have been identified for cutaneous malignant melanoma (CMM), but they account for

20 ons at this locus increase susceptibility to cutaneous malignant melanoma (CMM).

21 let light sensitivity in relation to risk of cutaneous malignant melanoma (CMM).

22 loci have been reproducibly associated with cutaneous malignant melanoma (CMM).

23 ary environmental risk factor for developing cutaneous malignant melanoma (CMM).

24 utations are present in approximately 50% of cutaneous malignant melanomas (CMMs).

25 The incidence of cutaneous malignant melanoma continues to increase every

26 A substantial part of cutaneous malignant melanomas develops from benign nevi.

27 vival for all patients with invasive primary cutaneous malignant melanoma diagnosed in Scotland, UK,

28 Previous linkage analyses of 19 cutaneous malignant melanoma/dysplastic nevi (CMM/DN) ki

29 Partial regression in cutaneous malignant melanoma has been reported by a numb

30 Cutaneous malignant melanoma in Sinclair swine is a here

31 Cutaneous malignant melanoma is a highly aggressive and

32 Cutaneous malignant melanoma is an aggressive cancer of

33 Cutaneous malignant melanoma is considered one of the mo

34 Cutaneous malignant melanoma is highly invasive and capa

35 These data suggest that the invasiveness of cutaneous malignant melanoma is influenced by variation

36 Cutaneous malignant melanoma is one of the fastest incre

37 Cutaneous malignant melanoma is rapidly increasing in th

38 The incidence of cutaneous malignant melanoma is undergoing a dramatic in

39 ive epidemiological data have indicated that cutaneous malignant melanoma may arise as a consequence

40 The accuracy of staging of cutaneous malignant melanoma patients by clinical and or

41 Twenty-six adult cutaneous malignant melanoma patients were enrolled in t

42 Imaging cutaneous malignant melanoma patients with the Fab fragm

43 dical, and particularly surgical, therapy of cutaneous malignant melanoma patients.

44 Cutaneous malignant melanoma remains a therapeutic chall

45 ar radiation, contributes to the etiology of cutaneous malignant melanoma, there are at present insuf

46 ted lymph node or in-transit metastasis from cutaneous malignant melanoma were randomly assigned to r

47 s responsible for the induction of mammalian cutaneous malignant melanoma whereas UVA is ineffective

48 A total of 114 patients with newly diagnosed cutaneous malignant melanoma who were at risk for region

49 have seen a steady rise in the incidence of cutaneous malignant melanoma worldwide.